WGS Q2 2023 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

Q2 2023 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$49M+34.7% YoY

Gross Profit

$19M38.5% margin

Operating Income

-$52M-106.0% margin

Net Income

-$47M-95.9% margin

EPS (Diluted)

$-1.84

QoQ Revenue Growth

+12.9%

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$56M

Stock-Based Comp.

$108,000

Balance Sheet

Total Assets

$476M

Total Liabilities

$180M

Stockholders' Equity

$296M

Cash & Equivalents

$157M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$36M	+34.7%
Gross Profit	$19M	-$30M	+163.4%
Operating Income	-$52M	-$163M	+68.3%
Net Income	-$47M	-$86M	+45.5%